title: Endometrial inositol phosphate turnover in pigs is reduced during pregnancy and estradiol-induced pseudopregnancy.
abstract: Three experiments were conducted to examine inositol phosphate (IP) turnover in response to treatments applied in vitro to endometrium from cyclic (CYC), pregnant (PREG) and estradiol-induced pseudopregnant (PSP) gilts. In Exp. 1, treatments (in 25 microliters .1 M NaHCO3) were 1) control (NaHCO3), 2) 125 ng oxytocin, 3) .25 micrograms prolactin, 4) 2.5 micrograms prolactin and 5) 5 micrograms pig conceptus secretory proteins (pCSP). Basal IP turnover on d 14 (estrus = d 0) for CYC was 3.9 to 5.0-fold greater than for PREG gilts and .6 to 1.1-fold greater than for PSP gilts (P less than .05). Oxytocin increased IP turnover 23 to 42% in CYC gilts (P less than .05), but not in PREG or PSP gilts. The treatment x reproductive status interaction (P less than .05) indicated that pCSP increased IP turnover 74 to 140% in PREG gilts but decreased it 18 to 22% in CYC and 17 to 50% in PSP gilts. In Exp. 2, treatments were applied in a 2 x 2 x 2 arrangement: 1) 0 or 125 ng oxytocin; 2) 0 or 2.5 micrograms prolactin and 3) 0 or 5 micrograms pCSP. Basal IP turnover on d 14 was 3.3 to 5.4-fold greater (P less than .05) in CYC than in PSP gilts and was affected by interaction (P less than .05) of pCSP and prolactin. Inositol phosphate turnover was increased by prolactin (12 to 22%) and by pCSP (7 to 34%) but, when combined, the stimulatory effects of each were eliminated.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: University of Florida, Gainesville 32611.
authors.forename: M A
authors.initials: MA
authors.lastname: Mirando
authors.forename: M P
authors.initials: MP
authors.lastname: Leën
authors.forename: S
authors.initials: S
authors.lastname: Beers
authors.forename: J P
authors.initials: JP
authors.lastname: Harney
authors.forename: F W
authors.initials: FW
authors.lastname: Bazer
mesh_terms: D000818:Animals; D004717:Endometrium / Q000187:drug effects / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology; D004971:Estrus / Q000378:metabolism; D005260:Female; D005326:Fetal Proteins / Q000494:pharmacology; D007295:Inositol Phosphates / Q000378:metabolism*; D009924:Organ Culture Techniques; D010121:Oxytocin / Q000494:pharmacology; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000378:metabolism*; D011388:Prolactin / Q000494:pharmacology; D011555:Pseudopregnancy / Q000378:metabolism / Q000662:veterinary*; D013552:Swine / Q000378:metabolism*; D013553:Swine Diseases / Q000378:metabolism*
chemical_list: D005326:Fetal Proteins; D007295:Inositol Phosphates; D004958:Estradiol; D010121:Oxytocin; D011388:Prolactin